Features
Law Firm Financial Impropriety
Funds can come up missing in any law firm, and the cause can be intentional theft that qualifies as fraud or embezzlement, or an unintentional mistake that shows poor judgment.
Features
Russian State Officials' Assets Abroad
Russian President Vladimir Putin has submitted two bills aimed at reducing public corruption by establishing various methods of control over the actions of public officials. Here's how this may affect U.S. companies doing business in Russia.
Navigating the FCPA in Healthcare and Life Sciences
It appears that the world of healthcare, pharmaceuticals, and medical devices will continue to figure prominently in FCPA enforcement. Here's why..
The Final Countdown
Regarding the Affordable Care Act, 2014 ushers in the most significant changes to date: the implementation of Health Benefit Exchanges (Exchanges) and employer "shared responsibility" provisions. Here's what you need to know.
Features
'Immediate and Appropriate Corrective Action'
Some employers may not be aware that their obligation to prevent harassment in the workplace extends to preventing harassment by non-employees, including, for example, customers, patients, and university students.
Features
How to Safely Navigate the New I-9 Minefield
Employers must use the latest version of Form I-9 bearing an edition date of March 8, 2013, and those that fail to do so may be subject to penalties enforced by Immigration and Customs Enforcement (ICE). Here's what you need to know.
Columns & Departments
Verdicts
An in-depth study of ruling of interest.
Columns & Departments
Drug & Device News
Review of the latest news.
Columns & Departments
Med Mal News
A look at several recent news items.
Features
Foreseeable Harm to Third Parties Keeps Claim Against Drug Makers Alive
Alabama's Supreme Court in January rendered a potentially far-reaching decision in a case pitting a consumer against drug manufacturers. While its holding applies only to cases brought in Alabama, the court's decision may lead to that state's becoming the preferred forum for certain types of drug litigation:
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Second Circuit Reinforces Bankruptcy Code Settlement Payment Safe HarborThe Second Circuit affirmed the lower courts' judgment that a "transfer made … in connection with a securities contract … by a qualifying financial institution" was entitled "to the protection of ... §546 (e)'s safe harbor ...."Read More ›
- The DOJ's New Parameters for Evaluating Corporate Compliance ProgramsThe parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.Read More ›
- The DOJ's Corporate Enforcement Policy: One Year LaterThe DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.Read More ›
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›
- Questions Every Law Firm Business Development Leader Should Be AskingIn a legal marketplace transformed by technology, heightened client expectations, and fierce competition, law firm leaders must approach strategy with rigor and clarity. The following questions, accompanied by relevant statistics and explanations, offer a focused guide for uncovering opportunity and driving sustainable growth.Read More ›
